Trademark: 86875240
Word
ERELIB
Status Date
Friday, October 6, 2023
Registration Number
5164031
Registration Date
Tuesday, March 21, 2017
Filing Date
Thursday, January 14, 2016
Published for Opposition
Tuesday, January 3, 2017
Cancellation Date
Friday, October 6, 2023
5 Pharmaceutical preparations for the treatment of diseases and disorders of the central and peripheral nervous system, and for the treatment of Parkinson's disease
Color is not claimed as a feature of the mark.
The wording "ERELIB" has no meaning in a foreign language.
Oct 6, 2023
Cancelled Sec. 8 (6-Yr)
Mar 21, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Mar 21, 2017
Registered-Principal Register
Jan 3, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 3, 2017
Published For Opposition
Dec 14, 2016
Notification Of Notice Of Publication E-Mailed
Nov 28, 2016
Law Office Publication Review Completed
Nov 17, 2016
Assigned To Lie
Nov 12, 2016
Approved For Pub - Principal Register
Nov 8, 2016
Teas/Email Correspondence Entered
Nov 8, 2016
Correspondence Received In Law Office
Nov 8, 2016
Assigned To Lie
Oct 27, 2016
Teas Response To Office Action Received
May 5, 2016
Teas Change Of Correspondence Received
Apr 30, 2016
Notification Of Non-Final Action E-Mailed
Apr 30, 2016
Non-Final Action E-Mailed
Apr 30, 2016
Non-Final Action Written
Apr 30, 2016
Assigned To Examiner
Jan 20, 2016
New Application Office Supplied Data Entered
Jan 18, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
